Scleroderma (systemic sclerosis) is associated with several autoantibodies, each of which
is useful in the diagnosis of affected patients and in determining their prognosis. Anti-…

… John D Reveille2, … John C Davis Jr3, … Ward MM, Weisman MH, Davis JC Jr, Reveille
JD. Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. …

The autoantibodies classically associated with systemic sclerosis (SSc; scleroderma)
include anticentromere antibodies (ACA) and anti–Scl-70 (otherwise known as anti–…

Objective. To provide a single source for the best available estimates of the US prevalence of
and number of individuals affected by arthritis overall, rheumatoid arthritis, juvenile arthritis, …

We have genotyped 14,436 nonsynonymous SNPs (nsSNPs) and 897 major histocompatibility
complex (MHC) tag SNPs from 1,000 independent cases of ankylosing spondylitis (AS), …

Objective To evaluate the safety and efficacy of adalimumab, a fully human recombinant IgG1
monoclonal antibody that specifically targets human tumor necrosis factor, in patients with …

Ankylosing spondylitis is a common form of inflammatory arthritis predominantly affecting
the spine and pelvis that occurs in approximately 5 out of 1,000 adults of European descent. …

Genome-wide association studies have recently identified at least 15 susceptibility loci for
systemic lupus erythematosus (SLE). To confirm additional risk loci, we selected SNPs from …

Ankylosing spondylitis is a common, highly heritable inflammatory arthritis affecting
primarily the spine and pelvis. In addition to HLA-B*27 alleles, 12 loci have previously been …

Objective To provide evidence‐based recommendations for the treatment of patients with
ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). Methods A core …